台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    90.0
  • 漲跌
    ▲1.0
  • 漲幅
    +1.12%
  • 成交量
    512
  • 產業
    上櫃 生技醫療類股
  • 117人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
訊聯 (1784)籌碼相關-兆豐-三民 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/247580859095May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

兆豐-三民 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/27289.9000.0089.0022340.85%
2025/03/26890.7800.0089.5082283.50%
2025/03/2500.00585.8088.50-5224-2.22%
2025/03/24585.500.285.5085.104.82232.17%
2025/02/12083.80083.7083.0004380.00%
2025/02/0500.00185.0084.60-1437-0.23%
2025/02/04183.1000.0083.1014380.23%
2024/12/19079.3000.0079.5005470.00%
2024/12/041102.501102.00100.5005500.00%
2024/10/0700.00199.8099.40-11,642-0.06%
2024/10/0100.001100.50102.00-11,687-0.06%
2024/09/301102.502102.25100.00-11,706-0.06%
2024/09/2600.002100.5098.50-21,964-0.10%
2024/09/24197.2000.0096.6012,2460.04%
2024/09/231100.501103.00100.0002,2430.00%
2024/09/193103.0000.00102.5032,2880.13%
2024/09/1100.001104.00102.00-12,425-0.04%
2024/09/101104.0000.00103.0012,4750.04%
2024/08/2200.001117.00114.50-13,003-0.03%
2024/08/213117.172118.75117.0012,9980.03%
2024/08/203119.832116.75116.0012,9730.03%
2024/08/1400.001113.50112.00-12,956-0.03%
2024/08/131107.5000.00113.5012,9810.03%
2024/08/0900.000.3107.20107.50-0.32,926-0.01%
2024/08/071108.5000.00108.5012,9060.03%
2024/08/0600.00098.70103.0002,8900.00%
2024/08/0500.003102.5099.50-32,853-0.11%
2024/08/020110.500.1112.00110.5002,8180.00%
2024/08/010118.9400.00117.0002,8020.00%
2024/07/295.2114.166117.67113.50-0.82,748-0.03%
2024/07/2600.002124.00126.00-22,692-0.07%
2024/07/221.1141.392138.55136.00-0.92,647-0.03%
2024/07/199162.115155.50145.5042,5720.16%
2024/07/182158.7500.00161.5022,3020.09%
2024/07/1700.002142.50147.00-22,211-0.09%
2024/07/152143.0000.00143.5022,1960.09%
2024/07/1000.000148.00147.5002,1440.00%
2024/07/0900.000145.00143.5002,1300.00%
2024/07/041131.501131.00135.5002,0270.00%
2024/07/0300.001136.50133.00-12,008-0.05%
2024/07/024140.252136.50140.0021,9350.10%
2024/07/018129.9412128.67139.50-41,729-0.23%
2024/06/285125.701124.50127.0041,6230.25%
2024/06/2400.00196.3094.20-11,371-0.07%
2024/06/21297.10194.5093.7011,3510.07%
2024/06/20295.85298.2099.4001,3080.00%
2024/06/1200.00283.8083.40-21,069-0.19%
2024/06/11484.03785.3982.80-31,051-0.29%
2024/06/07383.5700.0083.0031,0170.29%
2024/06/06281.5000.0081.2029690.21%
2024/05/3000.00475.5077.30-4607-0.66%
2024/05/2900.00274.1574.00-2547-0.37%
2024/05/2000.00169.5071.70-1471-0.21%
2024/05/17169.9000.0069.9014540.22%
2024/05/1300.00365.7065.50-3415-0.72%
2024/04/26267.8000.0066.4023550.56%
2024/04/23164.6000.0064.1012880.35%
2024/04/22261.5000.0060.8022780.72%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音